TDC
47
-10
FITB
58
5
SPG
53
2
SJM
34
6
LRCX
52
6
SNA
60
4
DTE
63
4
MMM
40
3
DNB
54
4
HBI
62
4
LB
52
3
ADM
33
5
EQT
57
15
FMC
36
6
FTI
55
2
UA
33
7
ZBH
59
3
URBN
30
3
OKE
70
3
BF.B
59
2
TDC
47
-10
FITB
58
5
SPG
53
2
SJM
34
6
LRCX
52
6
SNA
60
4
DTE
63
4
MMM
40
3
DNB
54
4
HBI
62
4
LB
52
3
ADM
33
5
EQT
57
15
FMC
36
6
FTI
55
2
UA
33
7
ZBH
59
3
URBN
30
3
OKE
70
3
BF.B
59
2
Financhill
Back

Arcus Biosciences Quote, Financials, Valuation and Earnings

How Banks Can Seize Your Accounts

Learn More
Buy
62

RCUS
Arcus Biosciences

Last Price:
16.92
Seasonality Move:
7.99%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Arcus Biosciences Price Quote

$16.92
-1.03 (-5.74%)
(Updated: September 16, 2024 at 4:00 PM ET)

Arcus Biosciences Key Stats

Buy
62
Arcus Biosciences (RCUS) is a Buy
Day range:
$17.42 - $18.28
52-week range:
$12.95 - $20.66
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.94
P/B ratio:
2.58%
Volume:
624.8K
Avg. volume:
592.3K
1-year change:
-13.37%
Market cap:
$1.6B
Revenue:
$117M
EPS:
$-3.09

How Much Does Arcus Biosciences Make?

Is Arcus Biosciences Growing As A Company?

  • What Is Arcus Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Arcus Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Arcus Biosciences Stock Price Performance

What Is Arcus Biosciences 52-Week High & Low?

Arcus Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arcus Biosciences?

  • How Much Debt Does Arcus Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Arcus Biosciences Have?
    Cash and short term investments quarterly total is $969M
  • What Is Arcus Biosciences’s Book Value Per Share?
    Book value per share is 6.96

Is Arcus Biosciences Cash Flow Positive?

  • What Is RCUS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$247M
  • What Is Arcus Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $240M
  • What Is Arcus Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$67M

Arcus Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RCUS return on invested capital is -43.08%
  • What Is Arcus Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -20.8%
  • What Is RCUS Return On Equity?
    ROE is a measure of profitability and is -43.08%

Arcus Biosciences Earnings Date & Stock Price

Arcus Biosciences Competitors

  • Who Are Arcus Biosciences's Competitors?
    Below is a list of companies who compete with Arcus Biosciences or are related in some way:
    • Clearside Biomedical Inc (CLSD)
    • Intra-Cellular Therapies Inc (ITCI)
    • Janux Therapeutics Inc (JANX)
    • Syndax Pharmaceuticals Inc (SNDX)
    • Trevena Inc (TRVN)

Arcus Biosciences Dividend Yield

Arcus Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 26.38%
Revenue: 34.48% 47.24%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 33.13
Upside from Last Price: 84.54%

Major Shareholders

  • How many RCUS shares are owned by institutional investors?
    98.7M RCUS shares are owned by institutional investors
  • How many RCUS shares are owned by insiders?
    5.1M RCUS shares are owned by insiders